Phio Pharmaceuticals Corp. (PHIO)
PHIO Stock Price Chart
Explore Phio Pharmaceuticals Corp. interactive price chart. Choose custom timeframes to analyze PHIO price movements and trends.
PHIO Company Profile
Discover essential business fundamentals and corporate details for Phio Pharmaceuticals Corp. (PHIO) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
10 May 2012
Employees
5.00
Website
https://www.phiopharma.comCEO
Robert J. Bitterman
Description
Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system. The company develops PH-762 that activates immune cells to recognize and kill cancer cells by reducing the expression of the checkpoint protein PD-1 for immunotherapy in adoptive cell transfer (ACT); PH-894 that silences the epigenetic protein BRD4, which is an intracellular regulator of gene expression for use in ACT; and PH-804 that targets the suppressive immune receptor TIGIT, which is a checkpoint protein present on T cells and natural killer cells for use in ACT. It has collaborations with AgonOx Inc. on clinical development of novel T cell-based cancer immunotherapies. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was incorporated in 2011 and is headquartered in Marlborough, Massachusetts.
PHIO Financial Timeline
Browse a chronological timeline of Phio Pharmaceuticals Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 May 2026
Upcoming earnings on 13 Nov 2025
EPS estimate is -$0.46.
Earnings released on 14 Aug 2025
EPS came in at -$0.45 falling short of the estimated -$0.36 by -25.00%.
Earnings released on 15 May 2025
EPS came in at -$0.41 .
Earnings released on 31 Mar 2025
EPS came in at -$0.85 surpassing the estimated -$1.23 by +30.89%, while revenue for the quarter reached $70.00K .
Earnings released on 14 Nov 2024
EPS came in at -$1.54 surpassing the estimated -$4.14 by +62.80%.
Earnings released on 14 Aug 2024
EPS came in at -$3.62 surpassing the estimated -$4.59 by +21.13%.
Stock split effective on 5 Jul 2024
Shares were split 1 : 9 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 9 May 2024
EPS came in at -$4.23 .
Earnings released on 1 Apr 2024
EPS came in at -$1.53 falling short of the estimated -$1.30 by -17.69%, while revenue for the quarter reached $30.00K .
Earnings released on 9 Nov 2023
EPS came in at -$10.26 surpassing the estimated -$12.87 by +20.28%.
Earnings released on 10 Aug 2023
EPS came in at -$13.23 .
Earnings released on 11 May 2023
EPS came in at -$28.35 .
Earnings released on 22 Mar 2023
EPS came in at -$2.40 surpassing the estimated -$3.24 by +25.93%.
Stock split effective on 26 Jan 2023
Shares were split 1 : 12 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 10 Nov 2022
EPS came in at -$28.09 falling short of the estimated $38.90 by -172.21%.
Earnings released on 11 Aug 2022
EPS came in at -$20.53 surpassing the estimated -$33.50 by +38.72%.
Earnings released on 12 May 2022
EPS came in at -$20.53 surpassing the estimated -$32.42 by +36.67%.
Earnings released on 22 Mar 2022
EPS came in at -$27.01 surpassing the estimated -$34.58 by +21.89%.
Earnings released on 10 Nov 2021
EPS came in at -$30.26 falling short of the estimated -$27.01 by -12.03%.
Earnings released on 12 Aug 2021
EPS came in at -$21.61 surpassing the estimated -$28.09 by +23.07%.
Earnings released on 13 May 2021
EPS came in at -$34.58 .
Earnings released on 25 Mar 2021
EPS came in at -$44.30 surpassing the estimated -$45.38 by +2.38%, while revenue for the quarter reached $0.00 .
Earnings released on 10 Nov 2020
EPS came in at -$43.22 falling short of the estimated -$41.06 by -5.26%.
PHIO Stock Performance
Access detailed PHIO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.